leptin fragments (Aegis)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Nameleptin fragments (Aegis)
Drug Alias NameD-Leu-OB3[D-Leu-4]-OB3MA-[D-Leu-4]-OB3
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionAppetite suppressantNeuroprotectantsLeptin receptor agonists
TargetsLeptin receptor
Therapy Area/IndicationsObesityDiabetes MellitusAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlbany Medical College
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesConsynance TherapeuticsAegis Therapeutics LLCAlbany Medical College
Active IndicationsN/A
Inactive IndicationsObesityDiabetes MellitusAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A